Stock Analysis
Haoxiangni Health FoodLtd First Quarter 2024 Earnings: EPS: CN¥0.03 (vs CN¥0.03 in 1Q 2023)
Haoxiangni Health FoodLtd (SZSE:002582) First Quarter 2024 Results
Key Financial Results
- Revenue: CN¥493.8m (up 19% from 1Q 2023).
- Net income: CN¥12.6m (up 2.6% from 1Q 2023).
- Profit margin: 2.6% (down from 3.0% in 1Q 2023).
- EPS: CN¥0.03 (in line with 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Haoxiangni Health FoodLtd's share price is broadly unchanged from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 3 warning signs for Haoxiangni Health FoodLtd (1 is a bit concerning) you should be aware of.
Valuation is complex, but we're helping make it simple.
Find out whether Haoxiangni Health FoodLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002582
Haoxiangni Health FoodLtd
Haoxiangni Health Food Co.,Ltd. engages in the research, development, procurement, production, and sale of healthy foods in China.
Excellent balance sheet second-rate dividend payer.